Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome

Quinn, T. J. , Myint, P. K., McCleery, J., Taylor-Rowan, M. and Stewart, C. (2020) Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database of Systematic Reviews, 2020(2), CD013540. (doi: 10.1002/14651858.cd013540)

Abstract

This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows: Primary objective: to assess whether ACB in older adults is a prognostic factor for future cognitive decline or dementia. Secondary objective(s): to assess whether ACB is a prognostic factor for older adults recruited in primary care, secondary care, or community settings (with setting used as the basis for subgroup analyses); whether ACB is associated with mortality; to compare the prognostic validity of respective ACB scales; and to examine the effect of duration of exposure and duration of follow‐up on the ACB‐dementia risk association.

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Taylor-Rowan, Dr Martin and Quinn, Professor Terry
• Authors: Quinn, T. J., Myint, P. K., McCleery, J., Taylor-Rowan, M., and Stewart, C.
• College/School: College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
• Journal Name: Cochrane Database of Systematic Reviews
• Publisher: Wiley
• ISSN: 1465-1858
• ISSN (Online): 1469-493X
• Copyright Holders: Copyright © 2020 The Cochrane Collaboration
• First Published: First published in 2020(2):CD013540
• Publisher Policy: Reproduced in accordance with the copyright policy of the publisher